Snell & Wilmer Represents Blueprint Equity in Growth Investment in Careflow

SAN DIEGO – Snell & Wilmer represented San Diego-based client Blueprint Equity, a technology-focused growth equity firm, in its investment in Careflow’s growth financing. Careflow is a CRM and referral intake platform designed to streamline administrative and financial workflows across the long-term post-acute care (“LTPAC”) sector.

Careflow addresses inefficiencies in referral management by consolidating patient and facility data into a unified system of record and automating workflows such as referral intake, admissions, case management, and contract management. The platform currently supports more than 500 facilities across skilled nursing and assisted living settings, with growing adoption among home health agencies and hospice providers.

“From the beginning, our goal has been to simplify the complex administrative workflows that our customers manage every day,” said Careflow Co-Founder Reuven Mashitz, in a recent press release. “As demand for the platform continues to grow, this partnership with Blueprint Equity helps us move faster across the board, from building new product features to supporting customers at scale and continuing to improve how operators manage referrals and admissions.”

Blueprint Equity’s investment will support Careflow’s continued platform expansion and growth. “From our earliest conversations, we were impressed by both the strength of the Careflow product and the team behind it,” added Bobby Ocampo, Managing Partner at Blueprint Equity. “We partnered with the team because of their deep understanding of the workflows inside skilled nursing facilities and home health agencies, and we believe Blueprint’s investment will enable Careflow to accelerate product innovation, expand its support infrastructure, and continue delivering exceptional value to its growing customer base.”

Bardia Moayedi led the Snell & Wilmer team advising Blueprint Equity. The diverse team included Sarah Hibbard, Monique Torres, Christopher Franich, and Bahar A. Schippel, P.C.

Snell & Wilmer’s corporate and securities attorneys have served as counsel to a substantial number of clients ranging from Fortune 100 companies to smaller emerging businesses. Our attorneys have provided sophisticated legal representation to biotech companies, health care and financial institutions, public utilities, homebuilders, transportation companies, restaurant and hospitality providers, athletic complexes, fitness facilities and many other types of businesses. Snell & Wilmer’s venture capital and private equity practice covers multiple aspects of the transactional arena involving public and private companies, including the structuring and execution of majority buyouts and minority investments, acquisitions (including buy- and sell-side deals, as well as negotiated and auction deals), financings (including 144A transactions and PIPEs), going-private transactions, and spin-off transactions. Our venture capital and private equity attorneys advise both domestic and international funds, including venture capital, private equity, hedge, mezzanine, real estate opportunity, fund-of-funds, exchange, and other private investment funds.